Vulvovaginal Disease

February 23, 2021

Fractional microblative CO2 laser therapy was found both effective and safe in treating vulvovaginal atrophy short term, according to a study in the journal Menopause.

February 17, 2021

Genitourinary Syndrome of Menopause is often overlooked by providers.

February 11, 2021

Researchers collected samples from 10 girls with vulvovaginitis and 16 healthy girls aged 3 to 9 years.

December 30, 2020

A case study on diagnosis and management. Could you recognize this rare condition?

December 11, 2020

Could you recognize this rare vulvar condition?

November 13, 2020

The etiology of this condition is unclear but is consistent with a loss of the normal vaginal flora and increase in inflammation.

October 02, 2020

This vulvar infection rarely is seen but presents an intriguing case.

September 30, 2020

Could you recognize this rare condition?

August 28, 2020

Considerable heterogeneity exists in reported outcomes and measures used in clinical trials of treatments for genitourinary syndrome of menopause (GSM), which impacts between 40% and 60% of postmenopausal women, according to a systematic review in the journal Menopause.

July 10, 2020

Results of a nationally representative study indicate that many young women receive bimanual pelvic exams (BPEs) and Pap tests that may be unnecessary, and not in compliance with the latest guidance from the American College of Obstetricians and Gynecologists (ACOG).

July 07, 2020

Candida albicans is the most common etiology for VCC and this study looked at what factors are associated with its molecular detection.

June 24, 2020

Recurrent or chronic vulvovaginitis is frustrating to patients and a burden to the health care system. Here is a guide to addressing it.

June 08, 2020

Would you be able to recognize this diagnosis in your practice?

May 13, 2020

For postmenopausal women with at least one vulvovaginal atrophy (VVA) symptom, the presence of physician-confirmed VVA is linked to significant impaired sexual function, according to a study from the European Vulvovaginal Epidemiological Survey (EVES).

May 13, 2020

A diagnosis of vulvovaginal atrophy (VVA) in breast cancer survivors is associated with a significant increase in the burden of illness and social costs, according to an Italian Delphi Panel in the journal Supportive Care in Cancer. These findings are primarily due to a rise in comorbidities and resource utilization, but adequate treatment might reduce the impact of the condition.

April 09, 2020

New research indicates having at least one symptom of vulvovaginal atrophy is linked to significant impaired sexual function for postmenopausal women.

November 27, 2019

Published research from Sexually Transmitted Diseases indicates a woman’s risk of vulvovaginal candidiasis could be increased by certain personal behaviors as well as the composition of her vaginal microbiota.

October 11, 2019

Although nearly half of postmenopausal women reported having vulvovaginal symptoms (VVS), only a minority discussed their symptoms during a well-woman visit with a primary care provider or gynecologist, according to recent survey analysis.

July 08, 2019

The safety and efficacy of targeting vulvovaginal tissues are the topic of this committee opinion.

June 14, 2018

The experimental agent TX-004HR effectively improved the vaginal mucosa of postmenopausal women with vulvovaginal atrophy (VVA) and reduced moderate-to-severe dyspareunia and vaginal dryness compared to placebo, according to results of a trial.